Escos SRL
1.7 FTEThe score of Escos shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +58 % Total assets +31 % Headcount (avg FTE) +21 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Escos's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 160,169 € | ||||
| Equity | 465,445 € | ||||
| Cash | 205,893 € | ||||
| EBITDA | 262,568 € | ||||
| Total assets | 927,153 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 13 Oct 2025
- Year ended 31 Dec 2023filed on 20 Sep 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Sep 2022
Escos's financial analysis
- Solvency50.2%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Escos
Escos's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0472.961.310
- VAT number
- BE0472961310
- Peppol
- Registered · 0208:0472961310 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Oct 2000
- Registered office
- 1480 Tubize
- Size
- Micro · 1.7 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Escos (SRL) has been based in Tubize since 2000, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 160,169 € and equity of 465,445 €; its revenue is not published. With 1.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 50.2%, above the median of its sector (43.9%).
Companies similar to Escos
Companies in the same business, of comparable size and area, outside its group.
- HEW Pharma Manufacture of pharmaceutical preparations Kalmthout · balance sheet €1.01m
- Phytos Wholesale of pharmaceutical and medical goods Kortrijk · balance sheet 2,672 €
- Dansaert APO Wholesale of pharmaceutical and medical goods Brussels · balance sheet 723,308 €
- mylife Diabetes Care Belgium Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €1.23m
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Dulis Wholesale of pharmaceutical and medical goods Namur · balance sheet 920,543 €
- Cooltube Wholesale of pharmaceutical and medical goods Kontich · balance sheet 899,612 €
- Esteve Pharmaceuticals Wholesale of pharmaceutical and medical goods Jette · balance sheet €2.91m
Frequently asked questions about Escos
What is the revenue of Escos?
Escos files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Escos?
In Belgium, the VAT number is the company number prefixed with BE: BE0472961310 for Escos, if the company is VAT-registered. Its company number (CBE) is 0472.961.310.
Where is the registered office of Escos?
According to the CBE register, the registered office of Escos is in 1480 Tubize.
What is the equity of Escos?
At the close of the 2025 financial year, the equity of Escos amounts to 465,445 €, a solvency of 50.2% of total assets.
How many people work at Escos?
1.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Escos?
The register lists 2 active mandates at Escos. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Escos
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →